Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
Last trade$1.91
Day change+$0.045 (+2.42%)
Day range$1.85 – $1.93
Volume1,564,736
Market cap$376M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$375.63M
Price / earnings
—
Price / book
4.96×
Price / sales
1.49×
EV / sales
1.68×
EV / EBITDA
-565.02×
Profitability
Earnings per share
-$0.04
Return on assets
-3.57%
Return on equity
-9.66%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.84×
Current ratio
1.96×
Quick ratio
1.15×
Cash ratio
0.2×
Cash flow
Price / cash flow
107.42×
Price / free cash flow
760.39×
Free cash flow
$494K
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for CERS, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$64.02M
$63.3M
$59.89M
$64.58M
$60.24M
$60.13M
$48.85M
$56.75M
Cost of revenue
$27.45M
$27.91M
$25.77M
$28M
$24.56M
$23.47M
$17.82M
$23.42M
Gross profit
$36.57M
$35.39M
$34.13M
$36.58M
$35.68M
$36.66M
$31.04M
$33.33M
Selling, general and administrative
$21.92M
$22.86M
$19.95M
$20.83M
$18.62M
$21.18M
$20.29M
$19.33M
Research and development
$14.27M
$14.39M
$14.53M
$16.39M
$15.83M
$18.9M
$16.61M
$15.44M
Total operating expenses
$36.19M
$37.25M
$34.48M
$37.22M
$34.44M
$40.08M
$36.89M
$34.78M
Operating income
$383K
-$1.86M
-$354K
-$641K
$1.24M
-$3.42M
-$5.85M
-$1.45M
Interest expense
-$1.24M
-$1.71M
-$1.87M
-$1.96M
-$2.12M
-$2.15M
-$2.11M
-$2.05M
Income before taxes
-$514K
-$2.89M
-$1.56M
-$2.07M
$65K
-$5.64M
-$7.64M
-$2.45M
Income taxes
$66K
$95K
$91K
$119K
$85K
$76K
$74K
$111K
Net income
-$580K
-$2.98M
-$1.65M
-$2.18M
-$20K
-$5.72M
-$7.72M
-$2.56M
Net income attributable to common shareholders
-$550K
-$2.94M
-$1.64M
-$2.18M
-$19K
-$5.71M
-$7.72M
-$2.52M
EBITDA
$804K
-$1.4M
$93K
-$248K
$1.62M
-$3.08M
-$5.55M
-$1.12M
Basic earnings per share
$0.00
-$0.01
-$0.01
-$0.01
$0.00
-$0.03
-$0.04
-$0.01
Diluted earnings per share
$0.00
-$0.01
-$0.01
-$0.01
$0.00
-$0.03
-$0.04
-$0.01
Recent news
Company coverage with links to the original publishers.
Cerus announced positive Phase III trial results for red blood cell pathogen reduction technology, a major market expansion opportunity. The company is shifting to higher-margin kit distribution for its fibrinogen complex product and achieved positive operating cash flow of $3 million. A partnership with Blood Centers of America is accelerating North American adoption, positioning the company toward GAAP profitability.
ASML reported strong Q2 results, but its stock fell in pre-market trading. Other companies like Cassava Sciences, Logistic Properties of the Americas, Five Below, Cerus, Clean Energy Fuels, and Spirit Airlines also saw their stocks decline.
Bloom Energy shares jumped 12.1% after announcing a strategic partnership with CoreWeave to deploy its fuel cells for on-site power generation at a data center. Several other stocks also saw significant pre-market movements, both positive and negative.
U.S. stock futures were mixed this morning, with the Dow futures falling by around 10 points on Monday.
Shares of Perion Network Ltd. (NASDAQ: PERI) fell sharply in today’s pre-market trading after the company slashed FY24 revenue guidance.
Perion Network said it sees first-quarter revenue of $157 million, versus market estimates of $175.53 million. The company said it now expects FY24 revenue of $590 million to $610 million, versus prior outlook of $860 million to $880 million.
Perion Network shares dipped 37.6% to $13.17 in pre-market ...
On Wednesday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Block Inc (NYSE:SQ) amidst Bitcoin (CRYPTO: BTC) prices recovering.
The Block Inc Trade
The sale, worth $3.5 million, was executed through Ark's flagship ARK Innovation ETF (NYSE:ARKK) and ARK Next Generation Internet ETF (NYSE:ARKW) with a total of 42,608 shares sold. The value of the trade, calculated from the latest closing price of $81.46. Notably, at the time of writing, Bitcoin traded nearly 6.6% higher at $67,330.71.
Ark has sold Block shares in every trading session of the current week. On Monday, Ark sold Block shares worth $8.95 million and on Tuesday, the firm sold $7.5 million worth. For the week, ...Full story available on Benzinga.com
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.